Item 9A. Controls and Procedures
Item
9A. Controls and Procedures.
Evaluation
of Disclosure Controls and Procedures
Disclosure
controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under
the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s
rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated
and communicated to our Management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of
the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under
the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective
as of December 31, 2025, due to a lack of properly designed, implemented, and effectively operating
controls.
42
In
light of this material weakness, we have enhanced our processes to identify and appropriately apply applicable accounting requirements
to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements including making
greater use of third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation
plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
We believe our efforts will enhance our controls relating to accounting for complex financial transactions, but we can offer no assurance
that our controls will not require additional review and modification in the future as industry accounting practice may evolve over time.
We
do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and
procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the
disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there
are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure
controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all
our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain
assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated
goals under all potential future conditions.
Management’s
Annual Report on Internal Control over Financial Reporting
This
Report does not include a report of Management’s assessment regarding internal control over financial reporting or an attestation
report of our registered public accounting firm due to a transition period established by the rules of the SEC for newly public companies.
Changes
in Internal Control over Financial Reporting
Not
applicable.
Item
9B. Other Information.
Trading
Arrangements
During
the quarterly period ended December 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange
Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,”
as each term is defined in Item 408(a) of Regulation S-K.
Additional
Information
None.
Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not
applicable.
43
PART
III
Item
10. Directors, Executive Officers and Corporate Governance.
Directors
and Executive Officers
As
of the date of this Report, our directors and officers are as follows:
Name
Age
Position
Ketan Seth
50
Chief Executive Officer and a Director
David Bauer
42
Director and Chief Financial Officer
General (Retired) Wesley Clark
81
Non-Executive Chairman of the Board
Kenneth Moritsugu
80
Director
Nadim Qureshi
51
Director
Dario Dino Ferrari
57
Director
The
experience of our directors and executive officers is as follows:
Ketan
Seth, a director since February 10, 2025 and our Chief Executive Officer since February 10, 2025 , has 20 years of
deal making experience in the tech sector as well as in the data centers space. Since October 2022, Mr. Seth has been the Chief Executive
Officer of Vezbi, the first American Super App focused on healthcare services such as telemedicine and small payment and remittance systems
for B2B clients both in the US as well as LatAm. In addition, since August 2020, Mr. Seth has been Chief Executive Officer of AT Health
Inc. (formerly Innovative Health Consulting LLC) and since January 2011, Mr. Seth has been managing partner of Alpha Trading LLC, a US
based private investment holding company focused on fintech and healthcare. From 2005 to 2012, Mr. Seth was Chief Executive Officer of
Innovative Logistics Solutions. From 2000 to 2004, Mr. Seth worked in the Deutsche Bank Investment Banking division, assisting on deal
flow and private placements. From 1998 to 2000, Mr. Seth served as a Business Strategy Consultant at Deloitte Consulting. Mr. Seth earned
a BA in Economics from University of Michigan and an MBA from the Stern School of Business at NYU, where he focused in Finance, Entrepreneurship
and Strategy. Mr. Seth is qualified to serve as a director on our Board due to his executive experience.
David Bauer, our
Chief Financial Officer since February 25, 2025 and a director since June 12, 2025, served as CEO and a director of Matters Media (now
Engrost Inc.), a digital media properties and management firm, from 2015 to January 2025, where he led all operations and M&A activity
for the holding company, including financial operations. From 2012 to 2015, Mr. Bauer was head of operations, M&A Advisory in the
financial services sector for Zenia Group. From 2007 to 2010, Mr. Bauer was employed by Goldman Sachs as a Financial Analyst in management,
trading and servicing of distressed and par loans and was leader of the synthetic bank loans team. Mr. Bauer is qualified to serve as
a director on our Board due to his financial and management experience.
General
(Retired) Wesley Clark , a director since June 12, 2025, has served as a member of the Board of Directors of ImmunityBio, Inc. (NASDAQ:
IBRX) since March 2021. Since 2003, he has served as chairman and chief executive officer of Wesley K. Clark & Associates,
LLC, a strategic consulting firm specializing in business development, crisis support and strategic communications. Since 2010, he has
served as chairman and chief executive officer of Enverra, Inc., a boutique investment bank. General Clark has been a director
of special purpose companies -- from December 14, 2021 to December 13, 2024, General Clark served as a director of Swiftmerge Acquisition
Corp., and from September 2005 to October 2009, General Clark was a director of Argyle Security, Inc., formerly Argyle Security
Acquisition Corporation. See “Prior SPAC Experience.” He served for 34 years in the U.S. Army, rising through the
ranks to earn his fourth star as a full general in 1996. He served as the Supreme Allied Commander Europe of NATO from 1997 to 2000,
where he commanded Operation Allied Force in the Kosovo War. Highly decorated throughout his career, Gen. Clark was awarded the
U.S. Presidential Medal of Freedom by President William J. Clinton. He has been a director of Directa Plus S.p.A.
since August 2022 and MCF Energy Ltd. since December 2022. Gen. Clark previously served on the boards of directors
of Equinox Gold Corp. from 2020 to 2023, and Rentech, Inc. from 2010 to 2018. He is a graduate of the U.S. Military Academy at West
Point, where he was class valedictorian. After graduating from West Point, he was awarded a Rhodes Scholarship to the University of Oxford
where he earned degrees in philosophy, politics and economics. He earned a master’s degree in military science from the Command
and General Staff College. Gen. Clark is qualified to serve as a director on our Board based on his extensive leadership experience,
success in both the public and private sectors, and experience serving on other public company boards of directors.
44
Dario
Dino Ferrari, director since June 12, 2025 , has been the President of Ferrari Express Inc. (“FEI”) since
June 2000. As the President and shareholder of Ferrari Express, he successfully broadened the company’s activities, particularly
in the fields of security and logistics, extending operations into Canada, Brazil, and Mexico. He also served as the CEO of Ferrari Logistics,
Inc., a New York-based logistics company, until it was merged with FEI in January 2016. Mr. Ferrari received a Law Degree from the Catholic
University of Milan. Mr. Ferrari is qualified to serve as a director on our Board because of his management experience.
Dr. Kenneth Moritsugu, director
since June 12, 2025, has been the President and Chief Executive Officer of First Samurai Consulting, LLC, a firm specializing in health
consulting focused on public health systems and policies, since 2007. Rear Admiral Moritsugu was the Acting Surgeon General of the United
States in 2002 and again from July 2006 to 2007, when he retired from the Commissioned Corps of the United States Public Health Service
(USPHS). Rear Admiral Moritsugu was a career officer in the USPHS for 37 years, where he served as the Deputy Surgeon General of the
United States from 1998. He also served in the following key HHS and government positions -- Director of the Division of Medicine, Deputy
Director of the Bureau of Health Professions, Director of the National Health Service Corps, and Assistant Bureau Director for Health
Services and Medical Director of the Federal Bureau of Prisons. From 2007, Dr. Moritsugu was the Vice President for Global Professional
Education and Strategic Relations for Johnson & Johnson’s Diabetes Solutions Companies, and former Worldwide Chairman of the
Johnson & Johnson (JJDI), until his retirement from Johnson & Johnson in 2013. He served as the Interim Chief Science and Medical
Officer of the American Diabetes Association from August 2019 through June 2020. Dr. Moritsugu attended Chaminade College of Honolulu
and earned a baccalaureate Degree with Honors from the University of Hawaii and a Master of Public Health in Health Administration and
Planning from the University of California, Berkeley. Dr. Moritsugu is Board certified in Preventive Medicine; holds Fellowships in the
American College of Preventive Medicine, the Royal Society of Public Health, the Royalty Society of Medicine, and the National Academy
of Public Administration; and is a Certified Correctional Health Professional. He is an Adjunct Professor of Global Health at the George
Washington University of Public Health and Adjunct Associate Professor of Preventive Medicine at the Uniformed Services University of
the Health Sciences. Dr. Moritsugu is qualified to serve as a director on our Board due to his management experience.
Nadim
Qureshi, director since June 12, 2025, is the managing partner of BPGC Management LP, a global private equity firm focused on
transactions with the global industrials, materials and chemicals sectors, which he co-founded in 2020, where he is responsible for all
aspects of firm and investment management. Mr. Qureshi has served as a director and officer of special purpose companies -- as Chairman
of the Board, Chief Executive Officer and a director of BPGC Acquisition Corp. (formerly known as Ross Acquisition Corp II) since November
12, 2024 and prior thereto as Head of M&A since its inception in January 2021, as Vice President and Chief Strategy Officer of Quinpario
Acquisition Corp. (“Quinpario”) from May 13, 2013 until June 30, 2014, and as a Managing Director for WL Ross & Co. LLC,
an affiliate of the sponsor of WL Ross Holding Corp., Mr. Qureshi supervised the Business Combination of WL Ross Holding Corp. with Nexeo
Solutions, Inc. and served as a board member of the combined company from 2016 to 2017. See “Prior SPAC Experience.” From
2018 to 2020, Mr. Qureshi served as Managing Partner at Invesco Private Markets, a private investing division of Invesco Ltd., an
investment management company, and from 2015 served as Managing Director, and as Managing Partner of WL Ross & Co. LLC, a private
equity firm focused on investments in financially distressed companies with undervalued stocks. which since 2006 has been operating
as a wholly owned subsidiary of Invesco Ltd. From 2012 to 2015, Mr. Qureshi was a Partner at Quinpario Partners LLC, a private equity
firm. From 2005 to 2012, he was a senior executive with Solutia, Inc. (as Senior Vice President, Emerging Markets from August 2011),
and part of the management team that led the restructuring and transformation of Solutia from a bankrupt commodity producer to a profitable
specialty chemicals business until its sale to Eastman Chemical in 2012. From 2000 to 2005, Mr. Qureshi worked at Arthur D. Little, a
global management consulting firm, and Charles River Associates, a global consulting firm. Mr. Qureshi also was a member of the Board
of Directors of International Seaways (NYSE:INSW) from July 2021 until February 2024 and Diamond S Shipping (NYSE:DSSI) from 2017 to
2021 (as Chairman from 2019 until its merger in 2021), Mr. Qureshi has a Bachelor of Science degree in Chemical Engineering and
a Master of Science degree in Micromolecular Science from Case Western Reserve University, as well as a Master of Business Administration
degree from Northwestern University. Mr. Qureshi is qualified to serve as a director on our Board due to his considerable experience
in investment, finance and mergers & acquisitions, as well as his managerial experience and service as a member of several public
companies, including SPACs.
45
Special
Advisors
William
(“Glenn”) Hill
Glenn
Hill, age 53, has been the CEO of the Studebaker Group, a multinational conglomerate with a strong background in defense and intelligence,
technology, mobility, finance, government, and critical industrial sectors, since February 2017. Since November 2021, he has been CEO
of the Security Council of the UN Alliance for Sustainable Development Goals. From July 2011 to March 2017, he was Executive Director
of Global Security for Blackspear Group. Mr. Hill has a strong network across the US, Africa, Europe and the Middle East, critical to
providing logistical support in challenging, fast-paced environments. Mr. Hill received an Associate’s degree from Columbus State
University and a Bachelor’s degree from KWU.
Mina
Janeska
Mina
Janeska, age 48, with 20 years of experience in real estate investment and asset management, including three years in the data centre
sector, is a trusted advisor in commercial strategy, market expansion, and sustainable investment. She has been the Chief Executive Officer
of Nvisio Ltd., a strategic advisory platform providing investment and acquisition support across digital infrastructure and real estate
that she founded, since November 2024. From May 2022 to October 2024, she was Commercial Director of Global Switch, a leading owner,
operator and developer of large scale, carrier and cloud-neutral, multi-customer data centres in Europe and Asia Pacific. From March
2018 to May 2021, Ms. Janeska was Asset Manager for Fidelity International Ltd., a UK real estate fund. Ms. Janeska received a BSc degree
in Urban Estate Management from University College Westminster and an MSc degree in Cognitive and Decision Sciences from University College
London.
Our
special advisors may assist our Management Team with sourcing and evaluating business opportunities and devising plans and strategies
to optimize any business that we acquire following the Initial Public Offering. However, unlike our Management Team, our special advisors
will not be responsible for managing our day-to-day affairs and will have no authority to engage in substantive discussions with Business
Combination targets on our behalf. For their services, each of our special advisors have received an indirect interest in 25,000 Founder
Shares through membership interests in BHM, which will transfer upon completion of our initial Business Combination. Our Sponsor also
has assigned 300,000 Founder Shares to Alberto Pontonio, a registered broker-dealer associated with Roberts & Ryan, co-manager of
the Initial Public Offering.
Family
Relationships
No
family relationships exist between any of our directors or executive officers.
Involvement
in Certain Legal Proceedings
There
are no material proceedings to which any director or executive officer has been involved in the last ten years that are material to an
evaluation of the ability or integrity of any director or officer.
Number
and Terms of Office of Officers and Directors
Our
Board of Directors consists of six members and is divided into three classes with only one class of directors being appointed in each
year, and with each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term.
Prior to the closing of our initial Business Combination, only holders of our Class B Ordinary Shares are entitled to vote on (i) the
appointment and removal of directors or (ii) continuing the company in a jurisdiction outside the Cayman Islands (including any Special
Resolution required to amend our constitutional documents or to adopt new constitutional documents, in each case, as a result of our
approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Our Public Shareholders are not entitled to
vote on such matters during such time. These provisions of our Amended and Restated Articles relating to these rights of holders of Class
B Ordinary Shares may be amended by a Special Resolution passed by the affirmative vote of at least 90% (or, where such amendment is
proposed in respect of the consummation of our initial Business Combination, two-thirds) of the votes cast by such shareholders as, being
entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company. The term
of office of the first class of directors, which consists of Dr. Kenneth Moritsugu and Dario Dino Ferrari, will expire at our first annual
general meeting. The term of office of the second class of directors, which consists of Nadim Qureshi and David Bauer, will expire at
the second annual general meeting. The term of office of the third class of directors, which consists of Ketan Seth and General (Ret.)
Wesley Clark, will expire at the third annual general meeting. In accordance with Nasdaq corporate governance requirements, we are not
required to hold an annual general meeting until one year after our first fiscal year end following our listing on Nasdaq.
46
Our
officers are appointed by the Board of Directors and serve at the discretion of the Board of Directors, rather than for specific terms
of office. Our Board of Directors is authorized to appoint officers as it deems appropriate pursuant to our Amended and Restated Articles.
Committees
of the Board of Directors
Our
Board of Directors has established two standing committees: the Audit Committee and the Compensation Committee. Subject to phase-in rules,
the Nasdaq Rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely
of independent directors. Each committee operates under a charter that has been approved by our Board and has the composition and responsibilities
described below.
Audit
Committee
Our
Board of Directors has established the Audit Committee. Dario Dino Ferrari, Nadim Qureshi and Kenneth Moritsugu serve as the members of
our Audit Committee. Under the Nasdaq Rules and applicable SEC rules, we are required to have three members of the Audit Committee, all
of whom must be independent. Dario Dino Ferrari, Nadim Qureshi and Kenneth Moritsugu are each independent.
Dario
Dino Ferrari serves as the chairman of the a Audit Committee. Each member of the Audit Committee is financially literate, and our Board
of Directors has determined that Mr. Ferrari qualifies as an “audit committee financial expert” as defined in applicable
SEC rules.
We
have adopted an Audit Committee charter, which details the principal functions of the Audit Committee, including:
● assisting
Board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements,
(3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our
internal audit function and independent registered public accounting firm; the appointment, compensation, retention, replacement, and
oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm
engaged by us;
● pre-approving
all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting
firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent registered public
accounting firm all relationships the independent registered public accounting firm have with us in order to evaluate their continued
independence;
● setting
clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least
annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s
internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer
review, of the independent registered public accounting firm, or by any inquiry or investigation by governmental or professional authorities,
within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with
such issues;
● meeting
to review and discuss our annual audited financial statements and quarterly financial statements with Management and the independent
registered public accounting firm, including reviewing our specific disclosures under “Management’s Discussion and Analysis
of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed
pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction;
● reviewing
with Management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or
compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports
that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards
or rules promulgated by the FASB, the SEC or other regulatory authorities;
47
● advising
the Board and any other Board committees if the clawback provisions of the SEC Clawback Rule are triggered based upon a financial statement
restatement or other financial statement change, with the assistance of Management and to the extent that our securities continue to
be listed on an exchange and subject to the SEC Clawback Rule; and
● implementing
and overseeing our cybersecurity and information security policies, and periodically reviewing the policies and managing potential cybersecurity
incidents.
Compensation
Committee
Our
Board of Directors has established the Compensation Committee The members of our Compensation Committee are Nadim Qureshi and Dario Dino
Ferrari. Mr. Ferrari serves as chair of the Compensation Committee. Under the Nasdaq Rules and applicable SEC rules, we are required
to have a compensation committee of at least two members, all of whom must be independent. Nadim Qureshi and Dario Dino Ferrari are each
independent.
We
have adopted a Compensation Committee charter, which details the principal functions of the Compensation Committee, including:
● reviewing
and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating
our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration
(if any) of our chief executive officers based on such evaluation;
● reviewing
and making recommendations to our Board of Directors with respect to the compensation, and any incentive compensation and equity-based
plans that are subject to board approval of all of our other officers;
● reviewing
our executive compensation policies and plans;
● implementing
and administering our incentive compensation equity-based remuneration plans;
● assisting
Management in complying with our proxy statement and annual report disclosure requirements;
● approving
all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and
employees;
● producing
a report on executive compensation to be included in our annual proxy statement;
● reviewing,
evaluating and recommending changes, if appropriate, to the remuneration for directors; and
● advising
the Board and any other Board committees if the clawback provisions of the SEC Clawback Rule are triggered based upon a financial statement
restatement or other financial statement change and perform any other tasks required of it by the Clawback Policy, with the assistance
of Management and to the extent that our securities continue to be listed on an exchange and subject to the SEC Clawback Rule.
The
charter also provides that the Compensation Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and is directly responsible for the appointment, compensation and oversight of the work of any such adviser.
However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the Compensation
Committee considers the independence of each such adviser, including the factors required by Nasdaq and the SEC.
48
Director
Nominations
We
do not have a standing nominating committee, though we intend to form a corporate governance and nominating committee as and when required
to do so by law or the Nasdaq Rules. In accordance with Rule 5605I(2) of the Nasdaq Rules, a majority of the independent directors
may recommend a director nominee for selection by our Board of Directors. Our Board of Directors believes that the independent directors
can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing
nominating committee. The directors who participate in the consideration and recommendation of director nominees are Nadim Qureshi and
Dr. Kenneth Moritsugu. In accordance with Rule 5605I(1)(A) of the Nasdaq Rules, all such directors are independent. As there
is no standing nominating committee, we do not have a nominating committee charter in place.
The
Board of Directors also considers director candidates recommended for nomination by our shareholders during such times as they are seeking
proposed nominees to stand for appointment at the next annual general meeting (or, if applicable, an extraordinary general meeting).
Our shareholders that wish to nominate a director for appointment to our board of directors should follow the procedures set forth in
our Amended and Restated Articles.
We
have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, our Board of Directors considers educational background, diversity of
professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent
the best interests of our shareholders. Prior to our initial Business Combination, our Public Shareholders do not have the right to recommend
director candidates for nomination to our Board of Directors.
Code
of Ethics
We have adopted the Code of
Ethics. If we make any amendments to our Code of Ethics other than technical, administrative or other non-substantive amendments, or grant
any waiver, including any implicit waiver, from a provision of the Code of Ethics applicable to our principal executive officer, principal
financial officer, principal accounting officer or controller or persons performing similar functions requiring disclosure under applicable
SEC rules or the Nasdaq Rules, we will disclose the nature of such amendment or waiver on our website. The information included on our
website is not incorporated by reference into this Report or in any other report or document we file with the SEC, and any references
to our website are intended to be inactive textual references only.
The
foregoing description of the Code of Ethics does not purport to be complete and is qualified in its entirety by the terms and conditions
of the Code of Ethics, a copy of which is attached hereto as Exhibit 14.
Trading
Policies
On
June 6, 2025, we adopted the Insider Trading Policy governing the purchase, sale, and/or other dispositions of our securities by directors,
officers and employees, which are reasonably designed to promote compliance with insider trading laws, rules and regulations, and applicable
Nasdaq Rules.
The
foregoing description of the Insider Trading Policy does not purport to be complete and is qualified in its entirety by the terms and
conditions of the Insider Trading Policy, a copy of which is attached hereto as Exhibit 19.
Item
11. Executive Compensation.
None
of our executive officers or directors have received any cash compensation for services rendered to us. We are not prohibited from paying
any fees (including advisory fees), reimbursements or cash payments to our Sponsor, officers or directors, or our or their affiliates,
for services rendered to us prior to or in connection with the completion of our initial Business Combination, including the following
payments, all of which, if made prior to the completion of our initial Business Combination, will be paid from funds held outside the
Trust Account:
● Repayment
of up to an aggregate of $300,000 in loans made to us by our Sponsor, pursuant to the IPO Promissory Note to cover offering-related and
organizational expenses;
● Reimbursement
for office space, utilities and secretarial and administrative support made available to us by BHM, the managing member of our Sponsor,
in an amount equal to $5,000 per month, pursuant to the Administrative Services Agreement;
49
● Payment
of consulting, success or finder fees to our Sponsor, directors, officers, advisors, or their respective affiliates in connection
with the consummation of our initial Business Combination;
● We
may engage our Sponsor or an affiliate of our Sponsor as an advisor or otherwise in connection with our initial Business Combination
and certain other transactions and pay such person or entity a salary or fee in an amount that constitutes a market standard for comparable
transactions;
● Reimbursement
for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial Business Combination;
● Repayment
of Working Capital Loans that may be made by our Sponsor or an affiliate of our Sponsor or certain of our officers and directors to finance
transaction costs in connection with an intended initial Business Combination. Up to $1,500,000 of such Working Capital Loans may be
convertible into units of the post-Business Combination entity at a price of $10.00 per unit at the option of the lender. Such units
(and underlying securities) would be identical to the Private Placement Units (and underlying securities). Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such Working
Capital Loans; and
● BHM
has allocated 75,000 Founder Shares to each of our Chief Executive Officer and Chief Financial Officer and 50,000 Founder Shares to each
of our independent directors, indirectly through membership interests in BHM, which will transfer upon completion of our initial Business
Combination.
After
the completion of our initial Business Combination, directors or members of our Management Team who remain with us may be paid consulting
or management fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in
the proxy solicitation materials or tender offer materials furnished to our shareholders in connection with a proposed initial Business
Combination, such as the Blockfusion Registration Statement. We have not established any limit on the amount of such fees that may be
paid by the combined company to our directors or members of Management. It is unlikely the amount of such compensation will be known
at the time of the proposed initial Business Combination, because the directors of the post-combination business will be responsible
for determining executive officer and director compensation.
Any
compensation to be paid to our executive officers will be determined, or recommended to the Board of Directors for determination, either
by the Compensation Committee or by a majority of the independent directors on our Board of Directors.
We
do not intend to take any action to ensure that members of our Management Team maintain their positions with us after the consummation
of our initial Business Combination, although it is possible that some or all of our officers and directors may negotiate employment
or consulting arrangements to remain with us after our initial Business Combination. The existence or terms of any such employment or
consulting arrangements to retain their positions with us may influence our Management’s motivation in identifying or selecting
a target business, but we do not believe that the ability of our Management to remain with us after the consummation of our initial Business
Combination will be a determining factor in our decision to proceed with any potential Business Combination. We are not party to any
agreements with our officers and directors that provide for benefits upon termination of employment.
For
more information on the employment agreements entered into in connection with the Blockfusion Business Combination, see Item 1.
“Business” and the Blockfusion Registration
Statement.
Compensation
Recovery and Clawback Policy
On
June 6, 2025, our Board of Directors approved the adoption of the Clawback Policy in order to comply with the SEC Clawback Rule, and
the Nasdaq Rules, as set forth in Nasdaq Listing Rule 5608. At no time during the fiscal year covered
by this Report were we required to prepare an accounting restatement that required recovery of an erroneously awarded compensation pursuant
to the Clawback Policy, a copy of which is attached hereto as Exhibit 97.
50
Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The following table sets forth
information regarding the beneficial ownership of our Ordinary Shares as of February 19, 2026 based on information obtained from the persons
named below, with respect to the beneficial ownership of Ordinary Shares, by:
● each
person known by us to be the beneficial owner of more than 5% of our issued and outstanding Ordinary Shares;
● each
of our executive officers and directors that beneficially owns our Ordinary Shares; and
● all
our executive officers and directors as a group.
In the table below, percentage
ownership is based on 27,962,163 Ordinary Shares, consisting of (i) 20,892,250 Class A Ordinary Shares and (ii) 7,069,913 Class B Ordinary
Shares, issued and outstanding as of February 19, 2026. On all matters to be voted upon, except for (x)
the appointment and removal of directors to the Board and (y) continuing our Company in a jurisdiction outside the Cayman Islands ,
holders of the Class A Ordinary Shares and Class B Ordinary Shares vote together as a single class, unless otherwise required by applicable
law. Currently, all of the Class B Ordinary Shares are convertible into Class A Ordinary Shares on a one-for-one basis.
Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all Ordinary
Shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the Rights as these Rights
are not exercisable within 60 days of the date of this Report.
Class A Ordinary Shares
Class B Ordinary Shares
Approximate
Name and Address of Beneficial Owner (1)
Number of
Shares
Beneficially
Owned
Approximate
Percentage
of Class
Number of
Shares
Beneficially
Owned(2)
Approximate
Percentage
of Class
Percentage
of Total
Outstanding
Ordinary Shares
Blue Holdings Sponsor LLC (3)(4)
391,000
1.9 %
6,769,913
95.8 %
25.6 %
Ketan Seth (3)(4)
391,000
1.9 %
6,769,913
95.8 %
25.6 %
General (Ret.) Wesley Clark (4)
—
—
—
—
—
Dario Dino Ferrari (4)
—
—
—
—
—
Kenneth Moritsugu (4)
—
—
—
—
—
Nadim Qureshi (4)
—
—
—
—
—
David Bauer (4)
—
—
—
—
25.6 %
All officers and directors as a group (6 persons)
391,000
1.9 %
6,769,913
95.8 %
25.6 %
Other 5% Shareholders
Sona Parties (5)
1,960,185
9.4
—
—
7.0 %
Tenor Parties (6)
1,596,000
7.6 %
—
—
5.7 %
LMR Parties (7)
1,550,000
7.4 %
—
—
5.5 %
Magnetar Parties (8)
1,200,000
5.7 %
—
—
4.3 %
(1) Unless
otherwise noted, the principal business address of each of the following entities or individuals is c/o Blue Acquisition Corp., 1601
Anita Lane, Newport Beach, CA 92660-4803.
(2) Interests
shown consist solely of Founder Shares, classified as Class B Ordinary Shares. Such Class B Ordinary Shares will automatically convert
into Class A Ordinary Shares concurrently with or immediately following the consummation of our initial Business Combination or earlier
at the option of the holder on a one-for-one basis, subject to adjustment.
(3)
Blue Holdings Sponsor LLC, our Sponsor, is the record holder of 6,769,913 Founder Shares. BHM is the managing member of our Sponsor, Blue Holdings Sponsor LLC, and Ketan Seth is the managing member of BHM. As the managing member of BHM, Mr. Seth holds voting and investment discretion with respect to the Ordinary Shares held of record by the Sponsor. Mr. Seth disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest he may have therein, directly or indirectly. All of our officers, directors and our advisors are members of BHM. Each such person disclaims any beneficial ownership of the reported Ordinary Shares, other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
51
(4)
Does not include indirect interest as a member of BHM, the managing member of the Sponsor. BHM has allocated 75,000 Founder Shares to each of our Chief Executive Officer and Chief Financial Officer, 50,000 Founder Shares to each of our independent directors, and 25,000 to each of our special advisors, indirectly through membership interests in BHM, which will transfer upon completion of our initial Business Combination. Dario Dino Ferrari has an indirect economic interest in BHM through his ownership of 10,000 Class B Units in BHM, representing Private Placement Units purchased by him for $100,000.
(5)
According to a Schedule 13G filed with the SEC on February 17, 2026 by (i) Sona Asset Management (US) LLC, a Delaware limited liability company (“Sona AM (US)”), (ii) Sona Asset Management (UK) LLP, a limited liability partnership formed under the laws of England and Wales (“Sona AM (UK)” and, together with Sona AM (US), collectively, the “Sona Asset Managers”), (iii) Sona Asset Management Limited, a private limited company incorporated under the laws of England and Wales (“SAML”), (iv) Sona Asset Management Cayman Limited, an exempted company incorporated in the Cayman Islands (“SAMCL” and, together with SAML, the “Sona Intermediate Companies”), and (v) John Aylward, a citizen of Ireland (“Mr. Aylward” and collectively with the Sona Asset Managers and the SONA Intermediary Companies, the “Sona Parties”). Sona Asset Managers serve as investment managers to certain funds including with respect to the Public Shares held by those funds. SAML is the principal owner of each of the Sona Asset Managers. SAMCL is the principal owner of SAML. Mr. Aylward is ultimately in control of the investment and voting decisions of the Sona Asset Managers and is the principal owner of SAMCL. Sona AM (US) is registered with the SEC as an investment adviser. Sona AM (UK) is registered with the UK Financial Conduct Authority. The principal business address of Sona AM (US) is 730 3rd Avenue, 26th Floor, New York, NY 10017. The principal business address of Sona AM (UK), SAML and Mr. Aylward is 19-21 St. James's Street, London, United Kingdom SW1A 1ES. The principal business address of SAMCL is c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands.
(6) According
to a Schedule 13G filed with the SEC on June 17, 2025 by (i) Tenor Capital Management Company, L.P, a Delaware limited partnership
(“Tenor Capital”), (ii) Tenor Opportunity Master Fund, Ltd. a Cayman Islands exempted company (the “Master Fund”)
and (iii) Robin Shah, a citizen of the United States (“Mr. Shah”, and collectively with Tenor Capital and the Master Fund,
the “Tenor Parties”). The Public Shares are held by the Master Fund and Tenor Capital serves as the investment manager to
the Master Fund. Mr. Shah serves as the managing member of Tenor Management GP, LLC, the general partner of Tenor Capital. By virtue
of these relationships, the Tenor Parties may be deemed to have shared voting and dispositive power with respect to the Public Shares
owned directly by the Master Fund. The principal business address of each of the Tenor Parties is 810 Seventh Avenue, Suite 1905, New
York, NY 10019.
(7)
According to a Schedule 13G filed with the SEC on February 17, 2026 by (i) LMR Partners LLP, a United Kingdom limited liability partnership (“LMR”), (ii) LMR Partners Limited, a Hong Kong corporation (“LMR Limited”), (iii) LMR Partners LLC, a Delaware limited liability company (“LMR LLC”), (iv) LMR Partners AG, a Swiss corporation (“LMR AG”), (v) LMR Partners (DIFC) Limited, an United Arab Emirates corporation (“LMR DIFC”), (vi) LMR Partners (Ireland) Limited, a limited company incorporated in Ireland (“LMR Ireland”, collectively with LMR, LMR Limited, LMR LLC, LMR AG and LMR DIFC, the “LMR Investment Managers”), (vii) Ben Levine, a citizen of the United Kingdom (“Mr. Levine”), and (viii) Stefan Renold, a citizen of Switzerland (“Mr. Renold”, collectively with the LMR Investment Managers and Mr. Levine, the “LMR Parties”). The LMR Investment Managers serve as the investment managers to certain funds with respect to the Public Shares held by certain funds. Messrs. Levine and Renold are ultimately in control of the investment and voting decisions of the LMR Investment Managers with respect to the securities held by certain funds. The principal business address of each of the LMR Parties is c/o LMR Partners LLP, 9th Floor, Devonshire House, 1 Mayfair Place, London, W1J 8AJ, United Kingdom.
(8) According
to a Schedule 13G filed with the SEC on August 8, 2025 by (i) Magnetar Financial LLC, a Delaware limited liability company (“Magnetar
Financial”), (ii) Magnetar Capital Partners LP, a Delaware limited partnership (“Magnetar Capital Partners”), (iii)
Supernova Management LLC, a Delaware limited liability company (“Supernova Management”), and (iv) David J. Snyderman, a citizen
of the United States (“Mr. Snyderman”, collectively with Magnetar Financial, Magnetar Capital Partners and Supernova Management,
the “Magnetar Parties”), in connection with Public Shares held for the following funds (collectively, the “Magnetar
Funds”) (a) Magnetar Constellation Master Fund, Ltd, Magnetar Xing He Master Fund Ltd, Magnetar SC Fund Ltd, Purpose Alternative
Credit Fund Ltd, all Cayman Islands exempted companies and (b) Magnetar Structured Credit Fund, LP, a Delaware limited partnership and
Magnetar Alpha Star Fund LLC, Magnetar Lake Credit Fund LLC, Purpose Alternative Credit Fund - T LLC, all Delaware limited liability
companies. Magnetar Financial serves as the investment adviser to the Magnetar Funds, and as such, Magnetar Financial exercises voting
and investment power over the Public Shares held for the Magnetar Funds’ accounts. Magnetar Capital Partners serves as the sole
member and parent holding company of Magnetar Financial. Supernova Management is the general partner of Magnetar Capital Partners. The
manager of Supernova Management is Mr. Snyderman. The principal business address of each of the Magnetar Parties is 1603 Orrington
Avenue, 13th Floor, Evanston, Illinois 60201.
Securities
Authorized for Issuance under Equity Compensation Plans
None.
Changes
in Control
None.
For more information on the Blockfusion Business Combination, please see Item 1. “Business”
and the Blockfusion Registration Statement.
Item
13. Certain Relationships and Related Transactions, and Director Independence.
On
February 20, 2025, our Sponsor paid $25,000, or approximately $0.004 per share, to cover certain of our offering costs in the Initial
Public Offering in exchange for 6,059,925 Founder Shares.
The
number of Founder Shares outstanding was determined based on the expectation that the total size of the Initial Public Offering would
be a maximum of 17,250,000 Public Units if the Over-Allotment Option was exercised in full, and therefore that such Founder Shares would
represent 26% of the outstanding Ordinary Shares after the Initial Public Offering (excluding the Private Placement Shares). We issued
an additional 1,009,988 Founder Shares to our Sponsor without payment of any additional consideration in a share capitalization in connection
with the increase in the maximum size of the Initial Public Offering from 17,250,000 Public Units to 21,025,000 Public Units. Up to 922,163
of the Founder Shares were to be surrendered for no consideration depending on the extent to which the Over-Allotment Option was exercised.
On June 16, 2025, the Underwriters fully exercised their Over-Allotment Option and such 922,163 Founder Shares were no longer subject
to forfeiture.
52
Our
Sponsor also has assigned 300,000 Founder Shares to Alberto Pontonio, a registered broker-dealer associated with Roberts & Ryan,
co-manager of the Initial Public Offering. Our Sponsor, our officers and directors and Alberto Pontonio are deemed to be our “promoters”
as such term is defined under the federal securities laws.
Simultaneously
with the closing of the Initial Public Offering and pursuant to the Private Placement Units Purchase Agreements, we completed the private
sale of an aggregate of 592,250 Private Placement Units to our Sponsor, BTIG and Roberts
& Ryan in the Private Placement at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to our Company
of $5,922,500. Of those 592,250 Private Placement Units, (i) the Sponsor purchased 391,000 Private Placement Units and (ii) BTIG
and Roberts & Ryan purchased 201,250 Private Placement Units The Private Placement Units (and underlying securities) are identical
to the Public Units (and underlying securities), so long as they are held by our Sponsor or its permitted transferees, the Private Placement
Units (and the underlying securities) (i) may not, subject to certain limited exceptions, be transferred, assigned or sold by the
holders until 30 days after the completion of our initial Business Combination and (ii) will be entitled to registration.
Prior
to or in connection with the completion of our initial Business Combination, there may be payment by the company to our Sponsor, officers
or directors, or our or their affiliates, of a finder’s fee, advisory fee, consulting fee or success fee for any services they
render in order to effectuate the completion of our initial Business Combination, which, if made prior to the completion of our initial
Business Combination, will be paid from funds held outside the Trust Account.
Commencing
on June 13, 2025, and until the completion of our Business Combination or liquidation, we reimburse BHM, the managing member of the Sponsor
$5,000 per month for office space, utilities, and secretarial and administrative support pursuant to the Administrative Services Agreement.
For the period from February 10, 2025 (inception) through December 31, 2025, we incurred $32,833 in fees for these services and paid
$27,833, resulting in an outstanding balance of $5,000 of which such amount is included in administrative services fee payable in the
balance sheet of the financial statements included elsewhere this Report.
Prior
to the closing of our Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $300,000 under the IPO Promissory
Note to cover expenses related to the Initial Public Offering. Such loans and advances were non-interest bearing and payable on the earlier
of December 31, 2025 or the completion of our Initial Public Offering. We had borrowed $193,236 under the IPO Promissory Note through
June 16, 2025, the consummation of the Initial Public Offering, and repaid $203,557 to the Sponsor to settle the balance on June 16,
2025. The overpayment of $10,321 was recorded as a related party receivable as of December 31, 2025. No additional borrowing is available
under the IPO Promissory Note.
In
addition, to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or
certain of our officers and directors or their affiliates may, but are not obligated to, loan us Working Capital Loans, as may be required.
If we complete a Business Combination, we will repay such Working Capital Loans. In the event that a Business Combination does not close,
we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from
our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be converted into units of the
post-Business Combination entity at a price of $10.00 per unit. The units (and underlying securities) would be identical to the Private
Placement Units (and underlying securities). Other than as set forth above, the terms of such Working Capital Loans, if any, have not
been determined and no written agreements exist with respect to such Working Capital Loans. As of December 31, 2025, we did not have
any borrowings under any Working Capital Loans.
We
have until the end of the Combination Period to consummate an initial Business Combination, or until such earlier liquidation date as
our Board of Directors may approve, to consummate our initial Business Combination. If we anticipate that we may be unable to consummate
our initial Business Combination within the Combination Period, we may seek shareholder approval to amend our Amended and Restated Articles
to further extend the Combination Period. If we seek shareholder approval for an extension, our Public Shareholders will be offered an
opportunity to redeem their Public Shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the
Trust Account, including interest earned thereon (less taxes payable, if any), divided by the number of then issued and outstanding Public
Shares, subject to applicable law.
53
Any
of the foregoing payments to our Sponsor, repayments of pursuant to the IPO Promissory Note issued to our Sponsor or repayments of any
Working Capital Loans prior to our initial Business Combination will be made using funds held outside the Trust Account.
After
our initial Business Combination, members of our Management Team who remain with us may be paid consulting, management or other fees
from the combined company with any and all amounts being fully disclosed to our shareholders, to the extent then known, in the proxy
solicitation or tender offer materials, as applicable, furnished to our shareholders, such as the Blockfusion Registration Statement.
It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time
of a general meeting held to consider our initial Business Combination, as applicable, as it will be up to the directors of the post-combination
business to determine executive and director compensation.
The
holders of (i) the Founder Shares, (ii) the Private Placement Units, (iii) Representative Shares and (iv) any private placement-equivalent
units issued in connection with the Working Capital Loans, if any (and in each case holders of their underlying securities, as applicable)
are entitled to registration rights pursuant to the Registration Rights Agreement, requiring us to register such securities for resale
(in the case of the Founder Shares, only after conversion to our Class A Ordinary Shares). The holders of the majority of these securities
are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have
certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of
a Business Combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act.
BTIG and Roberts & Ryan may only make a demand on one occasion and only during the five-year period beginning on the effective date
of the IPO Registration Statement. In addition, BTIG and Roberts & Ryan may participate in a “piggy-back” registration
only during the seven-year period beginning on the effective date of the IPO Registration Statement. We will bear the expenses incurred
in connection with the filing of any such registration statements.
Our
Sponsor, directors and officers and a certain advisor have also entered into the Letter Agreement with us, pursuant to which, they have
waived their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if we fail to
complete our initial Business Combination within the Combination Period. However, if they acquire Public Shares in or after the Initial
Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if we fail
to complete our initial Business Combination within the Combination Period. Additionally, pursuant to the Letter Agreement, our Sponsor,
directors and officers will not propose any amendment to our Amended and Restated Articles to modify (i) the substance or timing of our
obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of our Public Shares if we do not
complete our initial Business Combination within the Combination Period or (ii) any other material provisions relating to shareholders’
rights or pre-initial Business Combination activity, unless we provide our Public Shareholders with the opportunity to redeem their Public
Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, divided
by the number of then outstanding Public Shares.
For
more information on the agreements entered into in connection with the Blockfusion Business Combination, see Item 1. “Business”
and the Blockfusion Registration Statement.
Director
Independence
Nasdaq
Rules require that a majority of our Board of Directors be independent within one year of our Initial Public Offering. An “independent
director” is defined generally as a person who, in the opinion of the company’s board of directors, has no material relationship
with the listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the
company).. Our Board of Directors has determined that each of General (Ret.) Wesley Clark, Nadim Qureshi, Dario Dino Ferrari and Kenneth
Moritsugu are “independent directors” as defined in the Nasdaq Rules and applicable SEC rules. Our independent directors
have regularly scheduled meetings at which only independent directors are present.
54
Item
14 . Principal Accountant Fees and Services.
The
following is a summary of fees paid or to be paid to Elliott Davis for services rendered.
Audit
Fees
Audit
fees consist of the aggregate fees for professional services rendered for the audit of our year-end financial statements and services
that are normally provided by Elliott Davis in connection with regulatory filings. The aggregate fees of Elliott Davis for professional
services rendered for the (i) audit of our annual financial statements and (ii) review of the financial information included in our Forms
10-Q for the respective periods and other required filings with the SEC for the period from February 10, 2025 (inception) through December
31, 2025 totaled approximately $162,200. The above amounts include interim procedures and audit fees, as well as attendance at Audit
Committee meetings.
Audit-Related
Fees
Audit-related
fees consist of the aggregate fees billed for assurance and related services that are reasonably related to performance of the audit
or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that
are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay Elliott
Davis for any audit-related fees for the period from February 10, 2025 (inception) through December 31, 2025.
Tax
Fees
Tax
fees consist of the aggregate fees billed for professional services relating to tax compliance, tax planning and tax advice.
We did not pay Elliott Davis for tax services, planning or
advice for the period from February 10, 2025 (inception) through December 31, 2025.
All
Other Fees
All
other fees consist of the aggregate fees billed for all other services. We
did not pay Elliott Davis for any other services for the period from February 10, 2025 (inception) through December 31, 2025.
Pre-Approval
Policy
Our
Audit Committee was formed upon the consummation of our Initial Public Offering. As a result, the Audit Committee did not pre-approve
all of the foregoing services, although any services rendered prior to the formation of our Audit Committee were approved by our Board
of Directors. Since the formation of our Audit Committee, and on a going-forward basis, the Audit Committee has and will pre-approve
all auditing services and permitted non-audit services performed and to be performed for us by our auditors, including the fees and terms
thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the Audit Committee
prior to the completion of the audit).
55
PART
IV
Item
15. Exhibit and Financial Statement Schedules.
(a) The
following documents are filed as part of this Report:
(1) Financial
Statements
Page
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 149)
F-2
Financial
Statements:
Balance Sheet as of December 31, 2025
F-3
Statement of Operations for the period from February 10, 2025 (inception) through December 31, 2025
F-4
Statement of Changes in Shareholders’ Deficit for the period from February 10, 2025 (inception) through December 31, 2025
F-5
Statement of Cash Flows for the period from February 10, 2025 (inception) through December 31, 2025
F-6
Notes to Financial Statements
F-7
to F-20
(2) Financial
Statement Schedules
All
financial statement schedules are omitted because they are not applicable or the amounts are immaterial and not required, or the required
information is presented in the financial statements and notes thereto beginning on page F-1 of this Report.
(3) Exhibits
We
hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits that are incorporated herein by reference
can be inspected on the SEC website at www.sec.gov.
Item
16. Form 10-K Summary.
Omitted
at our Company’s option.
56
BLUE
ACQUISITION CORP.
INDEX
TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 149 ) F-2
Financial Statements:
Balance Sheet as of December 31, 2025 F-3
Statement of Operations for the period from February 10, 2025 (inception) through December 31, 2025 F-4
Statement of Changes in Shareholders’ Deficit for the period from February 10, 2025 (inception) through December 31, 2025 F-5
Statements of Cash Flows for the period from February 10, 2025 (inception) through December 31, 2025 F-6
Notes to Financial Statements F-7 to F-20
F- 1
Report
of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders
of Blue Acquisition Corp.
Opinion on the Financial Statements
We have audited the accompanying balance sheet
of Blue Acquisition Corp. (the “Company”) as of December 31, 2025, the related statement of operations, changes in shareholder’s
deficit, and cash flows for the period from February 10, 2025 (inception) through December 31, 2025, and the related notes (collectively
referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the period from
February 10, 2025, (inception) through December 31, 2025, in conformity with accounting principles generally accepted in the United States
of America.
Substantial Doubt about the Company’s Ability
to Continue as a Going Concern
The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has a working
capital deficiency, expects to incur significant costs in pursuit of its acquisition plans, and has stated that substantial doubt exists
about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are also described
in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (the “PCAOB”)
and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards
of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement,
whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but
not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly,
we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Elliott Davis, PLLC
We have served as the Company's auditor since 2025.
Charlotte, North Carolina
February 19, 2026
F- 2
BLUE
ACQUISITION CORP.
BALANCE SHEET
December 31,
2025
ASSETS
Current Assets:
Cash
$ 560,813
Prepaid expenses - current
82,032
Due from related party
15,410
Total Current Assets
658,255
Non-current Assets:
Cash and marketable securities held in Trust Account
205,642,100
Prepaid expenses – non-current
33,699
Total Non-current Assets
205,675,799
TOTAL ASSETS
$ 206,334,054
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable
$ 107,053
Accrued expenses
962,012
Administrative services fee payable – related party
5,000
Total Current Liabilities
1,074,065
Non-current Liabilities:
Deferred underwriter fee liability
7,043,750
Total Non-current Liabilities
7,043,750
TOTAL LIABILITIES
8,117,815
Commitments and Contingencies (Note 7)
Class A Ordinary Shares subject to possible redemption, $ 0.0001 par value; 20,125,000 shares issued and outstanding at redemption value
205,642,100
Shareholders’ Deficit
Preference shares, $ 0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
—
Class A Ordinary Shares, $ 0.0001 par value; 500,000,000 shares authorized; 767,250 shares issued and outstanding (excluding 20,125,000 shares subject to possible redemption)
77
Class B Ordinary Shares, $ 0.0001 par value; 50,000,000 shares authorized; 7,069,913 shares issued and outstanding
707
Additional paid-in capital
—
Accumulated deficit
( 7,426,645 )
Total Shareholders’ Deficit
( 7,425,861 )
TOTAL LIABILITIES, ORDINARY SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT
$ 206,334,054
The
accompanying notes are an integral part of these financial statements.
F- 3
BLUE
ACQUISITION CORP.
STATEMENT OF OPERATIONS
For the
Period
From
February 10,
2025
(Inception)
Through
December 31,
2025
Operating expenses:
Formation, general and administrative expenses
$ 227,082
Legal and accounting expenses
1,532,176
Administrative services fee – related party
32,833
Listing fees
49,583
Insurance expense
41,301
Total operating expenses
1,882,975
Loss from operations
( 1,882,975 )
Other income:
Income earned on cash and marketable securities held in Trust Account
4,392,100
Interest income on operating account
22,275
Other income
4,414,375
Net income
$ 2,531,400
Weighted average shares outstanding of redeemable Class A Ordinary Shares
12,260,769
Basic and diluted net income per share, redeemable Class A Ordinary Shares
$ 0.66
Weighted average shares outstanding of non-redeemable Class A and Class B Ordinary Shares
7,220,364
Basic and diluted net loss per share, non-redeemable Class A and Class B Ordinary Shares
$ ( 0.77 )
The
accompanying notes are an integral part of these financial statements.
F- 4
BLUE
ACQUISITION CORP.
STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE PERIOD FROM FEBRUARY 10, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional
Paid-in
Accumulated
Total
Shareholders’
Shares
Amount
Shares
Amount
Capital
Deficit
Deficit
Balance – February 10, 2025 (inception)
—
$ —
—
$ —
$ —
$ —
$ —
Class B Ordinary Shares issued to Sponsor (1)
—
—
7,069,913
707
24,293
25,000
Contribution for purchase of Private Placement Units
—
—
—
—
100,000
—
100,000
Issuance of Class A Ordinary Shares in Initial Public Offering
—
—
—
—
4,361,306
—
4,361,306
Sale of Private Placement Units
592,250
59
—
—
5,822,441
—
5,822,500
Sale of Representative Shares
175,000
18
—
—
1,749,982
—
1,750,000
Remeasurement of Class A Ordinary Shares to redemption value
—
—
—
—
( 12,058,022 )
( 9,958,045 )
( 22,016,067 )
Net income
—
—
—
—
—
2,531,400
2,531,400
Balance – December 31, 2025
767,250
$ 77
7,069,913
$ 707
$ —
$ ( 7,426,645 )
$ ( 7,425,861 )
(1) In
May 2025, the Company effected a share capitalization pursuant to which the Company issued an additional 1,009,988 Founder Shares
resulting in an aggregate of 7,069,913 Founder Shares outstanding to the Sponsor. All share and per share amounts have been retroactively
restated to reflect the share capitalization.
The
accompanying notes are an integral part of these financial statements.
F- 5
BLUE
ACQUISITION CORP.
STATEMENT OF CASH FLOWS
FOR
THE PERIOD FROM FEBRUARY 10, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025
Cash Flows from Operating Activities:
Net income
$ 2,531,400
Adjustments to reconcile net income to net cash used in operating activities:
Formation, general and administrative expenses paid by Sponsor under IPO Promissory Note – related party
1,089
Income earned on cash and marketable securities held in Trust Account
( 4,392,100 )
Changes in operating assets and liabilities:
Prepaid expenses
( 90,729 )
Due from related party
( 5,089 )
Accounts payable
107,053
Accrued expenses
962,012
Administrative services fee payable – related party
5,000
Net cash used in operating activities
( 881,364 )
Cash Flows from Investing Activities:
Purchase of treasury securities in Trust Account
( 201,250,000 )
Net cash used in investing activities
( 201,250,000 )
Cash Flows from Financing Activities:
Proceeds from issuance of Class A Ordinary Shares
201,250,000
Proceeds from sale of Private Placement Units
5,922,500
Payment of underwriting fees and reimbursements
( 4,100,000 )
Payment of IPO Promissory Note – related party
( 203,557 )
Excess cash contribution recorded under IPO Promissory Note – related party
167,147
Payment of offering costs
( 343,913 )
Net cash provided by financing activities
202,692,177
Net Change in Cash
560,813
Cash – Beginning of period
—
Cash – End of period
$ 560,813
Supplemental Non-Cash Investing and Financing Activities:
Deferred offering costs paid by Sponsor under IPO Promissory Note – related party
$ 25,000
Prepaid expenses paid by Sponsor under IPO Promissory Note – related party
$ 25,000
Initial fair value of Class A Ordinary Shares subject to possible redemption
$ 183,626,033
Remeasurement of Class A Ordinary Shares subject to possible redemption
$ 22,016,067
The
accompanying notes are an integral part of these financial statements.
F- 6
BLUE
ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER
31, 2025
Note 1 — Organization
and Business Operations
Blue
Acquisition Corp. (the “Company”) is a special purpose acquisition company incorporated as a Cayman Islands exempted company
on February 10, 2025 . The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
The Company is an early-stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early-stage
and emerging growth companies.
As
of December 31, 2025, the Company had not commenced any operations. All activity for the period from February 10, 2025 (inception) through
December 31, 2025 relates to the Company’s formation, the Initial Public Offering (as defined below), and subsequent to the Initial
Public Offering, identifying a target company for and consummating a Business Combination, including the Blockfusion Business Combination
(as defined and described below). The Company will not generate any operating revenues until after the completion of its initial Business
Combination, at the earliest. The Company generates non-operating income in the form of interest and dividend income on investments from
the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
The
Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the U.S. Securities and Exchange Commission
(the “SEC”) on May 14, 2025, as amended (File No. 333-287281), was declared effective on June 12, 2025 (the “IPO
Registration Statement”). On June 16, 2025, the Company consummated the initial public offering of 20,125,000 units (the “Public
Units”), which included the full exercise by the several underwriters of the Initial Public Offering (the “Underwriters”)
of their over-allotment option (the “Over-Allotment Option”) in the amount of 2,625,000 units (the “Option Units”),
at $ 10.00 per Public Unit, generating gross proceeds of $ 201,250,000 (the “Initial Public Offering”). Each Public Unit consists
of one Class A Ordinary Share, par value $ 0.0001 per share, of the Company (each, a “Class A Ordinary Share” and
with respect to the Class A Ordinary Shares included in the Public Units, the “Public Shares”) and one right to receive one-tenth
(1/10) of one Class A Ordinary Share upon the consummation of the initial Business Combination (each, a “Public Right”).
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 592,250 units (the “Private
Placement Units” and, together with the Public Units, the “Units”) at a price of $ 10.00 per Private Placement Unit,
in a private placement to (i) the Company’s sponsor, Blue Holdings Sponsor LLC (the “Sponsor”), (ii) BTIG, LLC, a
representative of the Underwriters (“BTIG”) and (iii) Roberts & Ryan, Inc., a co- manager of the Initial Public Offering
(“Roberts & Ryan”), generating gross proceeds of $ 5,922,500 (the “Private Placement”). Of those 592,250 Private
Placement Units, (x) the Sponsor purchased 391,000 Private Placement Units and (y) BTIG and Roberts
& Ryan purchased an aggregate of 201,250 Private Placement Units. Each Private Placement Unit consists of one Class A Ordinary Share
(each, a “Private Placement Share”) and one right to receive one-tenth (1/10) of one Class A Ordinary Share upon the consummation
of an initial Business Combination (each, a “Private Placement Right” and together with a Public Right, a “Right”).
Transaction
costs amounted to $ 13,262,661 , consisting of $ 4,025,000 of cash underwriting fee, the Deferred Fee (as defined in Note 7) of $ 7,043,750 ,
$ 1,750,000 for issuance of the Representative Shares (as defined in Note 7), and $ 443,911 of other offering costs.
The
Company’s management (“Management”) has broad discretion with respect to the specific application of the net proceeds
of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be generally
applied toward consummating a Business Combination (less the Deferred Fee).
The
Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80 % of the net
balance in the Trust Account (as defined below) (excluding the Deferred Fee held and taxes payable on the income earned on the Trust
Account, if any) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete
a Business Combination if the post-Business Combination company owns or acquires 50 % or more of the outstanding voting securities of
the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance
that the Company will be able to successfully effect a Business Combination.
F- 7
Following
the closing of the Initial Public Offering, on June 16, 2025, an amount of $ 201,250,000 ($ 10.00 per Unit) from the net proceeds of the
Initial Public Offering and the Private Placement, was placed in a trust account (the “Trust Account”), with Continental
Stock Transfer & Trust Company (“Continental”), acting as trustee. The funds are initially held in cash, including demand
deposit accounts at a bank, or invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money
market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government
treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the
intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the
Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at
any time (based on Management’s ongoing assessment of all factors related to the potential status under the Investment Company
Act), instruct Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account
in cash or in an interest bearing demand deposit account at a bank.
Except
with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any,
the proceeds from the Initial Public Offering and the Private Placement will not be released from the Trust Account until the earliest
of (i) the completion of the initial Business Combination, (ii) the redemption of the Public Shares if the Company is unable to complete
the initial Business Combination by March 16, 2027. 21 months from the closing of the Initial Public Offering or by such earlier liquidation
date as the Company’s board of directors may approve (the “Combination Period”), subject to applicable law, or (iii)
the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and
restated memorandum and articles of association (the “Amended and Restated Articles”) to modify (1) the substance or timing
of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100 % of the Public
Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions
relating to the rights of holders of Class A Ordinary Shares or pre-initial Business Combination activity. The proceeds deposited
in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the
claims of the holders of the Public Shares (the “Public Shareholders”).
The
Company will provide the Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion
of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination
or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval
of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public
Shareholders will be entitled to redeem their Public Shares at a per-share price, payable in cash, equal to the aggregate amount
then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination,
including interest earned on the funds held in the Trust Account (less taxes payable, if any, but without deduction for any excise or
similar tax that may be due or payable), divided by the number of then outstanding Public Shares, subject to the limitations. The amount
in the Trust Account was $ 10.21 per Public Share as of December 31, 2025. The Ordinary Shares (as defined in Note 2) subject to possible
redemption were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in
accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480,
“Distinguishing Liabilities from Equity”.
The
Company has only the duration of the Combination Period to complete the initial Business Combination. If the Company is unable to complete
its initial Business Combination within the Combination Period, the Company will as promptly as reasonably possible, but not more
than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable, if
any, and up to $ 100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will constitute full and complete payment for the Public Shares and completely extinguish Public Shareholders’ rights as shareholders
(including the right to receive further liquidation or other distributions, if any), subject to the Company’s obligations under
Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law.
F- 8
The
Sponsor, officers and directors and a certain advisor, have entered into a letter agreement, dated June 12, 2025 (the “Letter Agreement”),
with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (as
defined in Note 6) and Public Shares in connection with (x) the completion of the initial Business Combination or an earlier redemption
in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is
desirable to facilitate the completion of the initial Business Combination and (y) a shareholder vote to approve an amendment to the
Amended and Restated Articles to modify (1) the substance or timing of the Company’s obligation to allow redemption in connection
with the initial Business Combination or to redeem 100 % of the Public Shares if the Company has not consummated an initial Business Combination
within the Combination Period or (2) any other material provisions relating to shareholders’ rights or pre-initial Business Combination
activity; (ii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the
Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating
distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business
Combination within the Combination Period and to liquidating distributions from assets outside the Trust Account; and (iii) vote
any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market
and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements of Rule 14e-5 under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which would not be voted in favor of approving
the Business Combination) in favor of the initial Business Combination.
The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products
sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality
or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of
(i) $ 10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation
of the Trust Account, if less than $ 10.00 per Public Share due to reductions in the value of the Trust Account assets, less taxes payable,
if any, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver
of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims
under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933,
as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations,
nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company
believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot provide any assurance that
the Sponsor would be able to satisfy those obligations.
Blockfusion
Business Combination
On
November 19, 2025, the Company entered into a business combination agreement (the “Blockfusion BCA”) with (i) Blockfusion
USA, Inc., a Delaware corporation (“Blockfusion”), (ii) Blockfusion Data Centers, Inc., a Delaware corporation (“Pubco”),
(iii) Atlas I Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“SPAC Merger Sub”) and
(iv) Atlas Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (“Company Merger Sub”).
Pursuant
to the Blockfusion BCA and subject to the terms and conditions set forth therein, (i) on or prior to the closing (the “Closing”,
and the date and time of the Closing, the “Closing Date”) of the transactions contemplated by the Blockfusion BCA (the “Blockfusion
Business Combination”), the holders of Company Series Seed Preferred Stock (as defined in the Blockfusion BCA) and Series A Preferred
Stock (as defined in the Blockfusion BCA) shall convert all of their issued and outstanding shares of Company Preferred Stock (as defined
in the Blockfusion BCA) for shares of Company Series A Common Stock, par value $ 0.0001 per share and Company Series B Common Stock, par
value $ 0.0001 per share, at the applicable conversion ratio (including any accrued or declared but unpaid dividends) as set forth in
Blockfusion’s certificate of incorporation, as amended, (ii) and on the Closing Date, (A) SPAC Merger Sub will merge with
and into the Company, with the Company continuing as the surviving entity (the “SPAC Merger”) and, as a result of which,
each of the Company’s issued and outstanding securities immediately prior to the effective time of the SPAC Merger shall no longer
be outstanding and shall automatically be cancelled in exchange for which the Company’s security holders shall receive substantially
equivalent securities of Pubco, (B) Company Merger Sub will merge with and into Blockfusion, with Blockfusion continuing as the surviving
entity (the “Company Merger”, and together with the SPAC Merger, the “Mergers”), and as a result of which each
issued and outstanding security of Blockfusion immediately prior to the effective time of the Company Merger shall no longer be outstanding
and shall automatically be cancelled in exchange for which the security holders of Blockfusion shall receive shares of common stock,
par value $ 0.0001 per share, of Pubco, with holders of Company Series B Shares receiving shares of Pubco Class B common stock, par value
$ 0.0001 per share, which will have the same economic rights as the Pubco Class A Shares (as defined below), but will have the right to
20 votes per share for such Company Class B Shares (as defined in the Blockfusion BCA) and holders of Company Series A Shares (as defined
in the Blockfusion BCA) receiving Pubco Class A common stock, par value $ 0.0001 per share (“Pubco Class A Shares”) for such
Company Series A Shares. As a result of the Mergers and the other transactions of the Blockfusion Business Combination, the Company and
Blockfusion will become wholly-owned subsidiaries of Pubco, all upon the terms and subject to the conditions set forth in the Blockfusion
BCA, and Pubco will become a publicly traded company.
F- 9
Additionally,
at the Effective Time (as defined in the Blockfusion BCA), each outstanding and unexercised option to purchase Company Common Stock (as
defined in the Blockfusion BCA) will be assumed by and become an option of Pubco containing the same terms, conditions, vesting and other
provisions as are currently applicable to such Company Options (as defined in the Blockfusion BCA), provided that each Assumed Option
(as defined in the Blockfusion BCA) will be exercisable for the number of Pubco Class A Shares equal to the Exchange Ratio (as defined
in the Blockfusion BCA) multiplied by the number of Company Class A Shares subject to the Company Option as of immediately prior to the
Effective Time, rounded down to the nearest whole number, at an exercise price equal to the per share exercise price of the Company Option
divided by the Exchange Ratio, rounded up to the nearest whole cent.
Additionally,
at the Effective Time, each outstanding and unexercised warrant to purchase Company Common Stock (as defined in the Blockfusion BCA)
will be assumed by and become a warrant to purchase Pubco Class A Shares containing the same terms, conditions, vesting and other provisions
as are currently applicable to such Company Warrants (as defined in the Blockfusion BCA), provided that each Assumed Warrant (as defined
in the Blockfusion BCA) will be exercisable for the number of Pubco Class A Shares equal to the Exchange Ratio multiplied by the number
of Company Class A Shares subject to the Company Warrant as of immediately prior to the Effective Time, rounded up to the nearest whole
share, at an exercise price equal to the per share exercise price of the Company Warrant divided by the Exchange Ratio, rounded down
to the nearest whole cent.
For more information regarding the Blockfusion
BCA and the proposed Blockfusion Business Combination, see Item 1 “Business” of the Company’s Annual Report on Form
10-K for the fiscal year ended December 31, 2025, of which the accompanying financial statements and these notes thereto form a part,
as well as the registration statement on Form S-4, which includes a preliminary proxy statement/prospectus,
filed in connection with the Blockfusion Business Combination and which was initially filed by Pubco with the SEC on December 8, 2026,
as may be amended from time to time (File No. 333-291994) , and the other filings that the Company and Pubco may make from time
to time with the SEC.
Liquidity,
Capital Resources and Going Concern
As
of December 31, 2025, the Company had $ 560,813 cash and a working capital deficit of $ 415,809 . The Company’s liquidity needs through
December 31, 2025 have been satisfied through (i) a payment from the Sponsor of $ 25,000 in exchange for issuance of the Founder Shares
(see Note 5), (ii) a loan pursuant to the IPO Promissory Note (as defined in Note 6) and (iii) the net proceeds from the consummation
of the Initial Public Offering and the Private Placement held outside the Trust Account.
In
connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation
of Financial Statements—Going Concern”, Management has determined that the Company currently lacks the liquidity it needs
to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the accompanying
financial statements are issued, as it expects to continue to incur significant costs in pursuit of its acquisition plans. Although no
formal agreement exists, the Sponsor, certain directors and officers, or any of their respective affiliates may, but are not obligated
to, extend Working Capital Loans (as defined in Note 6), as needed. In addition, Management has determined that if the Company is unable
to complete an initial Business Combination within the Combination Period, then it will cease all operations except for the purpose of
liquidating. These conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern
one year from the date that the accompanying financial statements were issued. Management plans to consummate an initial Business Combination
prior to the end of the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities in the accompanying
financial statement should the Company be required to liquidate after March 16, 2027. There can be no assurance that the Company’s
plans to raise capital or to consummate an initial Business Combination, including the Blockfusion Business Combination, will be successful.
Note 2 — Significant
Accounting Policies
Basis
of Presentation
The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (“GAAP”) and pursuant to the rules and regulations of the SEC. In the opinion of Management, the accompanying
financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the
financial position, operating results and cash flows for the periods presented.
F- 10
Emerging
Growth Company Status
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as
amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute
payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial
accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the
requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not
to opt out of such extended transition period which means that when a standard is issued or revised and it has different application
dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time
private companies adopt the new or revised standard. This may make comparison of the accompanying financial statements with another public
company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used. The Company’s financial statements
have not been impacted by Section 102(b)(1) of the JOBS Act as of December 31, 2025.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying financial statements
and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Making
estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the accompanying financial statements, which Management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results
could differ significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $ 560,813 cash and no cash equivalents as of December 31, 2025.
Cash
Held in Trust Account
As
of December 31, 2025, the assets held in Trust Account, amounting to $ 205,642,100 , were held in marketable securities.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $ 250,000 . Any loss incurred or a lack of access
to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
F- 11
Offering
Costs Associated with the Initial Public Offering
The
Company complies with the requirements of the FASB ASC Topic 340-10-S99, “Accounting for Offering Costs”, and SEC Staff Accounting
Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that
are related to the Initial Public Offering. FASB ASC Topic 470-20, “Debt with Conversion and Other Options,” addresses the
allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to
allocate Initial Public Offering proceeds from the Units between Public Shares and Public Rights, using the residual method by allocating
Initial Public Offering proceeds first to assigned value of the Public Rights and then to the Public Shares. Offering costs allocated
to Public Shares were charged to temporary equity, and offering costs allocated to Public Rights and Private Placement Units were charged
to shareholders’ equity as the Rights, after Management’s evaluated that the Public Rights and Private Placement Units should
be accounted for under equity treatment.
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair
Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily
due to its short-term nature.
Fair
value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
● “Level
1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
● “Level
2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
and
● “Level
3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
Net
Income (Loss) Per Ordinary Share
The
Company has two classes of Ordinary Shares: Non-Redeemable Shares (as defined below) and Redeemable Shares (as defined below). “Non-Redeemable
Shares” do not have redemption rights to the amounts held in the Trust Account, and consist of the (i) Private Placement Shares
underlying the Private Placement Units sold in the Private Placement and (ii) Company’s Class B Ordinary Shares, par value $ 0.0001 per
share (the “Class B Ordinary Shares”, and together with the Class A Ordinary Shares, the “Ordinary Shares”).
“Redeemable Shares” have redemption rights to the amounts held in the Trust Account and consist of the Public Shares underlying
the Public Units issued at the Initial Public Offering.
The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The accompanying
statement of operations includes a presentation of income (loss) per Redeemable Shares and income (loss) per Non-Redeemable Shares following
the two-class method of income (loss) per Ordinary Shares. In order to determine the net income (loss) attributable to both the Redeemable
Shares and Non- Redeemable Shares, the Company first considered the total income allocable to both classes of Ordinary Shares. This is
calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement
of the Class A Ordinary Shares subject to possible redemption was treated as dividends paid to the Public Shareholders. Subsequent to
calculating the total income (loss) allocable to both classes of Ordinary Shares, the Company split the amount to be allocated using
the weighted average shares outstanding ratio for the Redeemable Shares and for the Non- Redeemable Shares for the period from February
10, 2025 (inception) through December 31, 2025.
The
Company has not considered the effect of the 2,012,500 Class A Ordinary Shares underlying the Public Rights or 59,225 Class A Ordinary
Shares underlying the Private Placement Rights in the calculation of diluted net income (loss) per share, since the exercise of such
Rights are contingent upon the occurrence of future events and the inclusion of such Rights would be anti-dilutive.
F- 12
The
following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per Ordinary
Share for each class of Ordinary Shares for the period from February 10, 2025 (inception) through December 31, 2025:
For the Period from
February 10, 2025
(inception) through
December 31,
2025
Net income
$ 2,531,400
Less: Remeasurement of Class A Ordinary Shares to redemption value
( 22,016,067 )
Net loss including accretion of Class A Ordinary Shares to redemption value
$ ( 19,484,667 )
For the Period from
February 10, 2025
(inception) through
December 31, 2025
Non-redeemable
Class A and
Redeemable
Class B
Class A
Ordinary
Shares
Ordinary
Shares
Total number of Ordinary Shares
7,837,163
20,125,000
Ownership percentage
28 %
72 %
Net income allocated by class
$ 618,008
$ 1,913,392
Less: Remeasurement of Class A Ordinary Shares to redemption value based on ownership percentage
( 6,170,606 )
( 15,845,461 )
Plus: Accretion applicable to remeasurement of redeemable Class A Ordinary Shares to redemption value
—
22,016,067
Total (loss) income based on ownership percentage
$ ( 5,552,599 )
$ 8,083,999
Weighted average Ordinary Shares outstanding
7,220,364
12,260,769
Basic and diluted net income (loss) per share
$ ( 0.77 )
$ 0.66
Income
Taxes
The
Company accounts for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset
and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed
for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible
amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.
Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. Management determined that the Cayman Islands is the Company’s major tax jurisdiction.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31,
2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of
any issues under review that could result in significant payments, accruals or material deviation from its position.
F- 13
The
Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently
not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s
tax provision was zero for the period presented.
Class
A Ordinary Shares Subject to Possible Redemption
The
Public Shares contain a redemption feature that allows for the redemption of such Public Shares in connection with the Company’s
liquidation, or if there is a shareholder vote or tender offer in connection with the initial Business Combination. In accordance with
FASB ASC Topic 480-10-S99, “Distinguishing Liabilities from Equity”, the Company classifies Class A Ordinary Shares subject
to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The
Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of Redeemable Shares to equal
the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized
the accretion from initial book value to redemption value. The change in the carrying value of Redeemable Shares will result in charges
against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A Ordinary
Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit
section of the accompanying balance sheets. As of December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected
in the accompanying balance sheets are reconciled in the following table:
Gross proceeds from Initial Public Offering
$ 201,250,000
Less:
Proceeds allocated to Public Rights
( 4,361,306 )
Offering costs allocated to Class A Ordinary Shares subject to possible redemption
( 13,262,661 )
Plus:
Accretion of Class A Ordinary Shares subject to possible redemption
22,016,067
Class A Ordinary Shares subject to possible redemption at December 31, 2025
$ 205,642,100
Rights
The
Company accounts for the Public Rights and Private Placement Rights issued in connection with the Initial Public Offering and the Private
Placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company
evaluated and classified the Rights under equity treatment at their assigned values.
Recent
Accounting Pronouncements
Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on the accompanying financial statements.
Note 3 — Initial
Public Offering
In
the Initial Public Offering on June 16, 2025, the Company sold 20,125,000 Public Units at a purchase price of $ 10.00 per Public Unit,
which includes the full exercise of the Over-Allotment Option in the amount of 2,625,000 Option Units. Each Public Unit consists of one
Public Share and one Public Right. Each ten Public Rights entitle the holder thereof to receive one Class A Ordinary Share at the closing
of an initial Business Combination. The Company will not issue fractional Class A Ordinary Shares.
Note 4 — Private
Placement
Simultaneously
with the closing of the Initial Public Offering, the Sponsor, BTIG and Roberts & Ryan
purchased an aggregate of 592,250 Private Placement Units, at a price of $ 10.00 per Private Placement Unit for an aggregate purchase
price of $ 5,922,500 . Of the 592,250 Private Placement Units, (i) the Sponsor purchased 391,000 Private Placement Units and (ii) BTIG
and Roberts & Ryan purchased an aggregate of 201,250 Private Placement Units. Each Private Placement Unit consists of one
Class A Ordinary Share and one Private Placement Right. A portion of the proceeds from the Private Placement was added to the net proceeds
from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination
Period, the proceeds from the Private Placement held in the Trust Account will be used to fund the redemption of the Public Shares (subject
to the requirements of applicable law). The Private Placement Units (and underlying securities) are identical to the Public Units (and
underlying securities), except as otherwise disclosed in the IPO Registration Statement.
F- 14
Note 5 — Segment
Information
FASB
ASC Topic 280, “Segment Reporting”, establishes standards for companies to report, in their financial statements, information
about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of
an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial
information is available that is regularly evaluated by the chief operating decision maker (the “CODM”), or group, in deciding
how to allocate resources and assess performance.
The
Company’s CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics
for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, Management
has determined that the Company only has one reportable segment.
The
CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported
on the accompanying statements of operations as net income or loss. The measure of segment assets is reported on the accompanying balance
sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM
reviews several key metrics included in net income or loss and total assets, which include the following:
December 31,
2025
Cash
$ 560,813
Cash and marketable securities held in the Trust Account
$ 205,642,100
Total assets
$ 206,334,054
For the
Period from
February 10,
2025
(Inception)
through
December 31,
2025
Operating loss
$ ( 1,882,975 )
Income earned on cash and marketable securities held in the Trust Account
$ 4,392,100
Net income
$ 2,531,400
The
CODM reviews operating loss to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar
transaction within the Combination Period. The CODM also reviews operating loss to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget. The CODM reviews income earned on cash and marketable securities held in
Trust Account to monitor and project the amount of funds the Company has, or may have, to effect a Business Combination. Operating loss
and income earned on cash and marketable securities held in Trust Account, as reported on the statement of operations, are the significant
segment information provided to the CODM on a regular basis. All other segment items included in net income are reported on the accompanying
statement of operations and described within their respective disclosures.
The
CODM reviews the position of cash available with the company to assess if the Company has sufficient resources available to discharge
its liabilities and future obligations and to monitor the amount of funds the Company has to pursue its initial Business Combination.
The CODM reviews the position of cash and marketable securities held in the Trust Account to monitor and project the amount of funds
the Company has, or may have, to effect a Business Combination. Cash and cash and marketable securities held in Trust Account, as reported
on the accompanying balance sheet, are the significant segment information provided to the CODM on a regular basis. All other segment
items included in total assets are reported on the accompanying balance sheet and described within their respective disclosures.
F- 15
Note 6 — Related
Party Transactions
Founder
Shares
On
February 20, 2025, the Sponsor made a capital contribution of $ 25,000 , or approximately $ 0.004 per share, through payments of offering
costs and expenses on the Company’s behalf, for which the Company issued 6,059,925 Class B Ordinary Shares to the Sponsor (such
shares, the “Founder Shares”). In May 2025, the Company effected a share capitalization pursuant to which the Company
issued an additional 1,009,988 Founder Shares resulting in an aggregate of 7,069,913 Founder Shares outstanding to the Sponsor, resulting
in a price per share of approximately $ 0.004 per share. All share and per-share amounts have been retroactively restated to reflect the
share capitalization. The Sponsor also has assigned 300,000 Founder Shares to Alberto Pontonio, a registered broker-dealer associated
with Roberts & Ryan, co-manager of the Initial Public Offering.
The
Founder Shares are designated as Class B Ordinary Shares and, except as described below, are identical to the Class A Ordinary
Shares included in the Units, and holders of Founder Shares have the same shareholder rights as Public Shareholders, except that (i)
the Founder Shares are subject to certain transfer restrictions, as described in more detail below, (ii) the Founder Shares are
entitled to registration rights; (iii) the Sponsor and the Company’s officers and directors and a certain advisor have entered
into the Letter Agreement with us, pursuant to which they have agreed to (A) waive their redemption rights with respect to their
Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial Business Combination, (B) waive
their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with a shareholder
vote to approve an amendment to the Amended and Restated Articles to modify (1) the substance or timing of the Company’s obligation
to allow redemptions in connection with the initial Business Combination or to redeem 100 % of the Public Shares if the Company has not
consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders’
rights or pre-initial Business Combination activity, (C) waive their rights to liquidating distributions from the Trust Account
with respect to their Founder Shares or Private Placement Shares if we fail to complete the initial Business Combination within the Combination
Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold
if the Company fails to complete the initial Business Combination within such time period and to liquidating distributions from assets
outside the Trust Account and (D) vote any Founder Shares and Private Placement Shares held by them and any Public Shares purchased
during or after the Initial Public Offering (including in open market and privately-negotiated transactions, aside from Public Shares
they may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor
of approving the Business Combination transaction) in favor of the initial Business Combination, (iv) the Founder Shares are automatically
convertible into Class A Ordinary Shares in connection with the consummation of the initial Business Combination or earlier at the
option of the holder on a one-for-one basis, subject to adjustment as described herein and in the Amended and Restated Articles, and
(v) prior to the closing of the initial Business Combination, only holders of the Class B Ordinary Shares are entitled to vote
on the appointment and removal of directors or continuing the Company in a jurisdiction outside the Cayman Islands (including any special
resolution required to amend its constitutional documents or to adopt new constitutional documents, in each case, as a result of our
approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands).
IPO
Promissory Note — Related Party
Prior
to the closing of the Initial Public Offering, the Sponsor agreed to loan the Company an aggregate of up to $ 300,000 (the “IPO
Promissory Note”) to be used for a portion of the expenses of the Initial Public Offering. The IPO Promissory Note was non-interest
bearing, unsecured and due at the earlier of December 31, 2025 or the closing of the Initial Public Offering. The loan was repaid out
of the $ 747,500 of offering proceeds that were allocated to the payment of offering expenses. As of June 16, 2025, the date the Company
consummated its Initial Public Offering, the Company had borrowed $ 193,236 under the IPO Promissory Note. On June 16, 2025, the Company
paid $ 203,557 to the Sponsor, resulting in an overpayment of $ 10,321 that is recorded as a related party receivable as of December 31,
2025. The IPO Promissory Note was repaid in full and is no longer available to the Company as of December 31, 2025.
Due
From Related Party
For
the period from February 10, 2025 (inception) through December 31, 2025, the Company made payments on behalf of a related party totaling
$ 5,089 . This amount is recorded as a related party receivable along with the $ 10,321 recorded as an overpayment for the IPO Promissory
Note balance at the closing of the Initial Public Offering, resulting in a due from related party balance of $ 15,410 as of December 31,
2025.
F- 16
Administrative
Services Agreement
Commencing
on June 13, 2025, the Company entered into an agreement with Blue Holdings Management LLC, (“BHM”) the managing member of
the Sponsor, to pay an aggregate of $ 5,000 per month for office space, utilities, and secretarial and administrative support. These monthly
fees will cease upon the completion of the initial Business Combination or the liquidation of the Company. For the period from February
10, 2025 (inception) through December 31, 2025, the Company recorded $32,833 to administrative services fee – related party on
the accompanying statement of operations, and has paid $ 27,833 as of December 31, 2025, resulting in an accrual of $ 5,000 to administrative
services fee payable – related party on the accompanying balance sheet.
Working
Capital Loans
In
order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, BHM or
certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may
be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company will repay such Working
Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside
the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account would be used for such repayment. Up to
$ 1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $ 10.00 per
unit. The units (and underlying securities) would be identical to the Private Placement Units (and underlying securities). Other than
as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect
to such Working Capital Loans. As of December 31, 2025, the Company did not have any borrowings under any Working Capital Loans.
Note 7 — Commitments
and Contingencies
Risks
and Uncertainties
The
Company’s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond
the Company’s control. The Company’s ability to consummate an initial Business Combination could be impacted by, among other
things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest
rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and
geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the
likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s
ability to complete an initial Business Combination.
Registration
Rights
The
holders of (i) Founder Shares, (ii) Private Placement Units (and their underlying securities), (iii) units that may be issued upon
conversion of any Working Capital Loans (and their underlying securities), if any, (iv) the Representative Shares, (v) any Class A
Ordinary Shares issuable upon conversion of the Founder Shares and (vi) any Class A Ordinary Shares held by the holders of the Founder
Shares prior to our Initial Public Offering, including our Sponsor, at the completion of the Initial Public Offering or acquired prior
to or in connection with the initial Business Combination, are entitled to registration rights pursuant to a registration rights agreement,
dated June 12, 2025, which the Company entered into with the Sponsor, the Company’s officers and directors, and the other holders
thereto. These holders are entitled to make up to three demands and have piggyback registration rights. The Company will bear the expenses
incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The
Company granted the Underwriters a 45 -day option from the date of the Initial Public Offering to purchase up to an additional 2,625,000
Option Units to cover over-allotments, if any. On June 16, 2025, the Underwriters fully exercised their Over-Allotment Option.
The
Underwriters were paid a cash underwriting discount of 2.00 % of the gross proceeds of the Initial Public Offering, or 4,025,000 in the
aggregate, payable upon the closing of the Initial Public Offering. Additionally, the Underwriters are entitled to a deferred underwriting
discount of 3.5 % of the gross proceeds of the Initial Public Offering, $ 7,043,750 in the aggregate (the “Deferred Fee”).
The Deferred Fee will be released to the Underwriters only on completion of an initial Business Combination. The Deferred Fee will be
payable as follows: (i) $0.20 per Public Unit sold in the Initial Public Offering shall be paid to the Underwriters in cash, and (ii)
$0.15 per Public Unit sold in the Initial Public Offering shall be paid to the Underwriters in cash based on the funds remaining in the
Trust Account after giving effect to Public Shares that are redeemed in connection with an initial Business Combination.
F- 17
Representative
Shares
The
Company issued to the Underwriters and/or their designees 175,000 Ordinary Shares (the “Representative Shares”) upon the
consummation of the Initial Public Offering. The Company accounted for the Representative Shares as a cost of the Initial Public Offering,
resulting in a charge directly to shareholders’ equity. The Underwriters (and any of their designees to whom the Representative
Shares are issued) agreed not to transfer, assign or sell any such shares without the Company’s prior consent until the completion
of a Business Combination. In addition, the Representative Shares are be deemed to be underwriting compensation by the Financial Industry
Regulatory Authority, Inc. (“FINRA”) pursuant to FINRA Rule 5110 and are, accordingly, subject to certain transfer restrictions
or a period of 180 days beginning on the date of commencement of sales of the Public Units in the Initial Public Offering.
Furthermore,
the Underwriters agreed (and any of their designees to whom the Representative Shares are issued agree) (i) to waive its redemption
rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of our initial Business
Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the
Company fails to complete a Business Combination within the Combination Period. In addition, the Representative Shares are not transferable,
assignable or saleable until 30 days after the completion of the initial Business Combination (except with respect to permitted
transferees as described in the IPO Registration Statement).
Note 8 — Shareholder’s
Deficit
Preference
Shares
The
Company is authorized to issue a total of 5,000,000 preference shares at par value of $ 0.0001 each. As of December 31, 2025, there were
no preference shares issued or outstanding.
Class A
Ordinary Shares
The
Company is authorized to issue a total of 500,000,000 Class A Ordinary Shares at par value of $ 0.0001 each. As of December 31, 2025
there were 767,250 Class A Ordinary Shares issued and outstanding, excluding 20,125,000 shares subject to possible redemption.
Class B
Ordinary Shares
The
Company is authorized to issue a total of 50,000,000 Class B Ordinary Shares at par value of $ 0.0001 each. On February 20, 2025,
the Sponsor made a capital contribution of $ 25,000 , or approximately $ 0.004 per share, through payments of offering costs and expenses
on the Company’s behalf, for which the Company issued 6,059,925 Founder Shares to the Sponsor. In May 2025, the Company effected
a share capitalization pursuant to which the Company issued an additional 1,009,988 Founder Shares resulting in an aggregate of 7,069,913
Founder Shares outstanding to the Sponsor, resulting in a price per share of approximately $ 0.004 per share. All share and per-share
amounts have been retroactively restated to reflect the share capitalization. As of December 31, 2025, there were 7,069,913 Class B Ordinary
Shares issued and outstanding.
The
Founder Shares will automatically convert into Class A Ordinary Shares in connection with the consummation of the initial Business
Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like. In the case that additional Class A Ordinary Shares, or any other equity-linked
securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection
with the closing of the initial Business Combination, the ratio at which Class B Ordinary Shares convert into Class A Ordinary
Shares will be adjusted (unless the holders of a majority of the outstanding Class B Ordinary Shares agree to waive such adjustment
with respect to any such issuance or deemed issuance) so that the number of Class A Ordinary Shares issuable upon conversion of
all Class B Ordinary Shares will equal, in the aggregate, 26 % of the sum of (i) the total number of all Ordinary Shares outstanding
upon the completion of the Initial Public Offering (including any Class A Ordinary Shares issued pursuant to the Over-Allotment
Option and excluding the securities underlying the Private Placement Units and the Class A Ordinary Shares underlying the Private
Placement Rights issued to the Sponsor), plus (ii) all Class A Ordinary Shares and equity-linked securities issued or deemed
issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued,
or to be issued, to any seller in the initial Business Combination and any private placement-equivalent rights issued to the Sponsor,
BHM, certain of the Company’s officers or directors, or any of their respective affiliates upon conversion of working capital loans)
minus (iii) any redemptions of Public Shares by Public Shareholders in connection with an initial Business Combination; provided
that such conversion of Founder Shares will never occur on a less than one-for-one basis.
F- 18
Except
as set forth below, holders of record of the Ordinary Shares are entitled to one vote for each share held on all matters to be voted
on by shareholders. Unless specified in the Amended and Restated Articles or as required by the Companies Act (As Revised) of the Cayman
Islands or stock exchange rules, an ordinary resolution under Cayman Islands law and the Amended and Restated Articles, which requires
the affirmative vote of at least a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person
or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter
voted on by the Company’s shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which
(except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being
entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting (a “Special Resolution”),
and pursuant to the Amended and Restated Articles, such actions include amending the Amended and Restated Articles and approving a statutory
merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following
the initial Business Combination, the holders of more than 50 % of the Ordinary Shares voted for the appointment of directors can appoint
all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class B Ordinary Shares
(i) have the right to vote on the appointment and removal of directors and (ii) are entitled to vote on continuing the Company
in a jurisdiction outside the Cayman Islands (including any Special Resolution required to amend the Amended and Restated Articles or
to adopt new constitutional documents, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction
outside the Cayman Islands). Holders of the Class A Ordinary Shares are not entitled to vote on these matters during such time.
These provisions of the Amended and Restated Articles may only be amended if approved by a Special Resolution passed by the affirmative
vote of at least 90 % (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds)
of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable
general meeting of the Company.
Rights
Except
in cases where the Company is not the surviving company in a Business Combination, each holder of a Right will automatically receive
one tenth (1/10) of one Class A Ordinary Share upon consummation of the initial Business Combination. In the event the Company is not
the surviving Company upon completion of the initial Business Combination, each holder of a Right will be required to affirmatively convert
its Rights in order to receive the one tenth (1/10) of one Class A Ordinary Share underlying each Right upon consummation of the Business
Combination. The Company will not issue fractional shares in connection with an exchange of Rights. Fractional shares will either be
rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman Islands law. As
a result, a shareholder of the Company must hold Rights in multiples of 10 in order to receive shares for all of his or her Rights upon
closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the Combination Period
and the Company redeems the Public Shares for the funds held in the Trust Account, holders of Rights will not receive any of such funds
for their Rights and the Rights will expire worthless.
Note 9 — Fair
Value Measurements
At
December 31, 2025, the Company’s marketable securities held in the Trust Account were valued at $ 205,642,100 . The marketable securities
held in the Trust Account must be recorded on the accompanying balance sheet at fair value and are subject to remeasurement at each balance
sheet date. With each remeasurement, the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s
statement of operations.
The
following table presents the fair value information, as of December 31, 2025, of the Company’s financial assets that were accounted
for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine
such fair value. The Company’s marketable securities held in the Trust Account are based on dividend and interest income and market
fluctuations in the value of invested marketable securities, which are considered observable. The fair value of the marketable securities
held in trust is classified within Level 1 of the fair value hierarchy.
F- 19
The
following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities that were accounted for
at fair value on a recurring basis:
(Level 1)
(Level 2)
(Level 3)
As of December 31, 2025
Assets:
Cash and marketable securities held in Trust Account
$ 205,642,100
$ —
$ —
The
fair value of the Public Rights was $ 4,361,306 , or $ 0.23 per Public Rights as of June 16, 2025, the date of the consummation of the Initial
Public Offering. The fair value of the Public Rights is classified within Level 3 of the fair value hierarchy. The Public Rights have
been classified within shareholders’ equity and do not require remeasurement after issuance. The following table presents the quantitative
information regarding market assumptions used in the valuation of the Public Rights:
June 16,
2025
Implied Ordinary Share price
$ 9.77
Probability of acquisition
60 %
Calculated value per Public Right
$ 0.23
Note 10 — Subsequent
Events
The Company evaluated
subsequent events and transactions that occurred after December 31, 2025, the balance sheet date, through the date that the accompanying
financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the accompanying financial statements.
F- 20
EXHIBIT
INDEX
No.
Description
of Exhibit
1
Underwriting Agreement, dated June 12, 2025, by and between the Company and BTIG, as representative of the Underwriters. (2)
2
Business Combination Agreement, dated as of November 19, 2025, by and among the Company., Blockfusion, Pubco and the Merger Subs.+ † (3)
3
Amended and Restated Memorandum and Articles of Association of the Company. (2)
4.1
Form of Specimen Unit Certificate. (1)
4.2
Form of Specimen Class A Ordinary Share Certificate. (1)
4.3
Form of Specimen Share Right Certificate (see Exhibit A to Exhibit 4.4). (1)
4.4
Share Rights Agreement, dated June 12, 2025, by and between the Company and Continental. (2)
4.5
Description
of Registered Securities.*
10.1
Promissory Note, dated February 20, 2025, issued to the Sponsor. (1)
10.2
Securities Subscription Agreement, dated February 20, 2025, by and between the Company and the Sponsor. (1)
10.3
Investment Management Trust Agreement, dated June 12, 2025, by and between the Company and Continental. (2)
10.4
Registration Rights Agreement, dated June 12, 2025, by and among the Company, the Sponsor, BTIG, Roberts & Ryan and the other parties signatory thereto. (2)
10.5
Private Placement Units Purchase Agreement, dated June 12, 2025, between the Company and the Sponsor. (2)
10.6
Private Placement Units Purchase Agreement, dated June 12, 2025, between the Company, BTIG and Roberts & Ryan. (2)
10.7
Letter Agreement, dated June 12, 2025, by and among the Company, Sponsor and each of the officers, directors and advisors of the Company, and the other parties signatory thereto. (2)
10.8
Form of Indemnity Agreement. (2)
10.9
Administrative Services Agreement, dated June 12, 2025, between the Company and Blue Holdings Management LLC. (2)
10.10
Form of Company Support Agreement, dated as of November 19, 2025, by and among the Company, Blockfusion and the holders party thereto.+ † (3)
10.11
Form of Lock-Up Agreement, dated as of November 19, 2025, by and among the Company, Pubco and the holders party thereto. (3)
10.12
Insider Letter Amendment, dated as of November 19, 2025, by and among the Company, the Sponsor, BTIG, Pubco and the other parties thereto. (3)
10.13
Form of Non-Competition and Non-Solicitation Agreement, dated as of November 19, 2025, by and among the Company, Blockfusion, Pubco and the holders party thereto. † (3)
10.14
Form of Amended and Restated Registration Rights Agreement. (3)
14
Code of Business Conduct and Ethics, adopted June 6, 2025.(1)
19
Insider
Trading Policies and Procedures,, adopted June 6, 2025.*
31.1
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2
Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1
Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2
Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
97
Executive
Compensation Clawback Policy, adopted June 6, 2025.*
99.1
Audit Committee Charter. (1)
99.2
Compensation Committee Charter. (1)
101.INS
Inline XBRL Instance Document.*
101.SCH
Inline XBRL Taxonomy Extension
Schema Document.*
101.CAL
Inline XBRL Taxonomy Extension
Calculation Linkbase Document.*
101.DEF
Inline XBRL Taxonomy Extension
Definition Linkbase Document.*
101.LAB
Inline XBRL Taxonomy Extension
Label Linkbase Document.*
101.PRE
Inline XBRL Taxonomy Extension
Presentation Linkbase Document.*
104
Cover Page Interactive
Data File (Embedded as Inline XBRL document and contained in Exhibit 101).*
* Filed
herewith.
** Furnished
herewith.
+ The
exhibits and schedules to this Exhibit have been omitted in accordance with Item 601(b)(2) of Regulation S-K. The Company agrees to furnish
supplementally to the SEC a copy of all omitted exhibits and schedules upon its request.
† Certain
personally identifiable information has been omitted from this Exhibit pursuant to Item 601(a)(6) of Regulation S-K.
(1) Incorporated
by reference to the Company’s Registration Statement on Form S-1 (File No. 333-287281), filed with the SEC on May 14, 2025.
(2) Incorporated
by reference to the Company’s Current Report on Form 8-K, filed with the SEC on June 17, 2025.
(3) Incorporated
by reference to the Company’s Current Report on Form 8-K, filed with the SEC on November 19, 2025.
57
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned, thereunto duly authorized.
February 19, 2026
BLUE ACQUISITION CORP.
By:
/s/ Ketan Seth
Name:
Ketan Seth
Title:
Chief Executive Officer
(Principal Executive Officer)
Pursuant
to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.
Name
Position
Date
/s/ Ketan Seth
Chief Executive Officer and Director
February 19, 2026
Ketan Seth
(Principal Executive Officer)
/s/ David Bauer
Chief Financial Officer and Director
February 19, 2026
David Bauer
(Principal Financial and Accounting Officer)
/s/ General (Retired) Wesley Clark
Non-Executive Chairman of the Board
February 19, 2026
General (Retired) Wesley Clark
/s/ Kenneth Moritsugu
Director
February 19, 2026
Kenneth Moritsugu
/s/ Nadim Qureshi
Director
February 19, 2026
Nadim Qureshi
/s/ Dario Dino Ferrari
Director
February 19, 2026
Dario Dino Ferrari
58
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.